Related Experiment Videos

Decreased uptake of orotate in kidney tumors

Cancer Biochemistry Biophysics
|January 1, 1976
PubMed

Insights

Kidney tumors show significantly reduced uptake of orotate and uracil compared to normal kidney cortex in rats. This indicates altered metabolite uptake patterns in renal neoplasia.

Area of Science:

  • Biochemistry
  • Oncology
  • Nephrology

Background:

  • Kidney tumors exhibit distinct metabolic profiles compared to normal kidney tissue.
  • Understanding the uptake of nucleobase precursors is crucial for cancer research.

Purpose of the Study:

  • To investigate the uptake patterns of orotate and uracil in transplanted kidney tumors in rats.
  • To compare metabolite uptake in tumor tissue versus normal kidney cortex and medulla.

Main Methods:

  • Intraperitoneal injection of 3H-labeled orotate and uracil in rats with transplanted kidney tumors.
  • Quantification of isotope uptake in tumor, kidney cortex, and kidney medulla tissue fractions.
  • Analysis of incorporation into RNA and acid-soluble fractions.

Main Results:

  • Kidney tumors showed less than 5% of the 3H-labeled orotate uptake observed in host kidney cortex.
  • Orotate incorporation into RNA was significantly lower in kidney tumors compared to normal kidney cortex.
  • Uracil-3H uptake in kidney tumors was approximately 40% of that in the kidney cortex, with orotate uptake showing the reverse trend.
  • Orotate uptake and RNA incorporation were higher in kidney cortex than medulla, and decreased with age in rats.

Conclusions:

  • Renal neoplasia in rats is associated with an altered pattern of orotate and uracil uptake.
  • The reduced uptake of these metabolites in kidney tumors suggests potential differences in nucleotide biosynthesis pathways.

Related Concept Videos